BUSINESS● LOWAug 14 · Aug 14, 2026, 10:55 AM
CASI Pharmaceuticals GAAP EPS of -$0.97, revenue of $9.8M
Seeking Alpha Tech
CASI Pharmaceuticals has reported its GAAP EPS of -$0.97 and revenue of $9.8 million. This is a routine financial performance update for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoGalleon Gold increases bought deal private placement of shares to $27MSeeking Alpha TechBUSINESS22m agoTech stocks had a nice oversold bounce on Monday. Earnings this week will determine if it's for realCNBC